Role of Stress and Inflammation in the Etiology, Treatment, and Management of Premenstrual Dysphoric Disorder (PMDD)

Authors

  • Nithara Murthy UTCOMLS student Author
    • Sabrina Khuder University of Toledo College of Medicine and Life Sciences Author
      • Manasa Swaminathan University of Indianapolis image/svg+xml Author

        DOI:

        https://doi.org/10.46570/utjms-2026-1688

        Keywords:

        inflammation, women's health, depression, stress, suicide

        Abstract

        According to the DSM-5, Premenstrual Dysphoric Disorder (PMDD) is defined as a mood disorder characterized by physical, emotional, and behavioral symptoms that occur during the luteal phase and cause significant distress or impairment. While epidemiological studies highlight that PMDD occurs in 1.8-5.8% of menstruating individuals, this is a vast underestimation prevalence due in part to cultural and systematic factors that impact diagnosis. That said, it is imperative to conduct research on this debilitating condition and its impact on overall wellbeing. The objective of this review is to explore the role stress and inflammation plays on etiology, treatment, and management of PMDD. To ensure a thorough review, the inclusion criteria focused on studies published in peer reviewed journals on etiology (stress and inflammation in relation to PMDD) and the treatment and management of PMDD. Studies conducted on topics pertaining to genetics and serotonin dysregulation were not included. Additionally, research conducted prior to 2005 were also excluded from the review process. Overall, existing literature demonstrates that stress and inflammation has been found in individuals with PMDD. However, more research must be done on the potential  therapeutic value of Yaz, other COCs, and anti-inflammatory agents in treatment of PMDD. 

        375 223

        References

        References

        American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787 DOI: https://doi.org/10.1176/appi.books.9780890425787

        Cary, E., & Simpson, P. (2024). Premenstrual disorders and PMDD - a review. Baillière’s Best Practice & Research. Clinical Endocrinology & Metabolism, 38(1), Article 101858. https://doi.org/10.1016/j.beem.2023.101858 DOI: https://doi.org/10.1016/j.beem.2023.101858

        Faucher, J., Koszycki, D., Bradwejn, J., Merali, Z., & Bielajew, C. (2016). Effects of CBT versus MBSR treatment on social stress reactions in social anxiety disorder. Mindfulness, 7(2), 514-526. DOI: https://doi.org/10.1007/s12671-015-0486-4

        Fenton, C., Wellington, K., Moen, M. D., & Robinson, D. M. (2007). Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen) A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris. Drugs, 67(12), 1749-1765. DOI: https://doi.org/10.2165/00003495-200767120-00007

        Foidart, J. M., Sulak, P. J., Schellschmidt, I., Zimmermann, D., & Yasmin® Extended Regimen Study Group. (2006). The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days. Contraception, 73(1), 34-40. DOI: https://doi.org/10.1016/j.contraception.2005.06.068

        Fleshner, M., Frank, M., & Maier, S. F. (2017). Danger signals and inflammasomes: stress-evoked sterile inflammation in mood disorders. Neuropsychopharmacology, 42(1), 36-45. DOI: https://doi.org/10.1038/npp.2016.125

        Gold, E. B., Wells, C., & Rasor, M. O. N. (2016). The association of inflammation with premenstrual symptoms. Journal of women's health, 25(9), 865-874. DOI: https://doi.org/10.1089/jwh.2015.5529

        ?Liu, Y. Z., Wang, Y. X., & Jiang, C. L. (2017). Inflammation: the common pathway of stress-related diseases. Frontiers in human neuroscience, 11, 316. DOI: https://doi.org/10.3389/fnhum.2017.00316

        Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014). Inflamed moods: a review of the interactions between inflammation and mood disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 53, 23-34. DOI: https://doi.org/10.1016/j.pnpbp.2014.01.013

        Sack, M., Lempa, W., & Lamprecht, F. (2007). Assessment of psychophysiological stress reactions during a traumatic reminder in patients treated with EMDR. Journal of EMDR Practice and Research, 1(1), 15-23. DOI: https://doi.org/10.1891/1933-3196.1.1.15

        Sangthawan, M., & Taneepanichskul, S. (2005). A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 ?g on premenstrual symptoms. Contraception, 71(1), 1-7. DOI: https://doi.org/10.1016/j.contraception.2004.07.010

        Segerstrom, S. C., & Miller, G. E. (2004). Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological bulletin, 130(4), 601. DOI: https://doi.org/10.1037/0033-2909.130.4.601

        Downloads

        Published

        2026-02-17

        Issue

        Section

        Perspectives in Psychiatry: A Learner’s Viewpoint

        How to Cite

        1.
        Murthy N, Khuder S, Swaminathan M. Role of Stress and Inflammation in the Etiology, Treatment, and Management of Premenstrual Dysphoric Disorder (PMDD). Translation. 2026;15(S1). doi:10.46570/utjms-2026-1688

        Similar Articles

        31-40 of 82

        You may also start an advanced similarity search for this article.

        Most read articles by the same author(s)